Literature DB >> 8140053

Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism.

A Tsuji1, H Takanaga, I Tamai, T Terasaki.   

Abstract

The pH-dependent transcellular transport of [14C]benzoic acid across a Caco-2 cell monolayer is shown to be mediated by a monocarboxylic acid-specific carrier-mediated transport system, localized on the apical membrane. Evidence for the carrier-mediated transport of benzoic acid includes (a) the significant temperature and concentration dependence, (b) the metabolic energy dependence, (c) the inhibition by unlabeled benzoic acid and other monocarboxylic acids, (d) countertransport effects on the uptake of [14C]benzoic acid, and (e) effects of a proteinase (papain) and amino acid-modifying reagents. Furthermore, since carbonylcyanide p-trifluoromethoxyphenylhydrazone and nigericin significantly inhibited the transport of [14C]benzoic acid, the direct driving force for benzoic acid transport is suggested to be the inwardly directed proton gradient. From these results, together with previous observations using intestinal brush border membrane vesicles, the pH dependence of the transcellular transport of certain organic weak acids across Caco-2 cells is considered to result mainly from a proton gradient-dependent, carrier-mediated transport mechanism, rather than passive diffusion according to the pH-partition theory.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8140053     DOI: 10.1023/a:1018933324914

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa.

Authors:  A R Hilgers; R A Conradi; P S Burton
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

2.  pH-dependent intestinal transport of monocarboxylic acids: carrier-mediated and H(+)-cotransport mechanism versus pH-partition hypothesis.

Authors:  A Tsuji; M T Simanjuntak; I Tamai; T Terasaki
Journal:  J Pharm Sci       Date:  1990-12       Impact factor: 3.534

3.  Participation of monocarboxylic anion and bicarbonate exchange system for the transport of acetic acid and monocarboxylic acid drugs in the small intestinal brush-border membrane vesicles.

Authors:  M T Simanjuntak; T Terasaki; I Tamai; A Tsuji
Journal:  J Pharmacobiodyn       Date:  1991-09

4.  Inactivation of the renal microvillus membrane Na+-H+ exchanger by histidine-specific reagents.

Authors:  F G Grillo; P S Aronson
Journal:  J Biol Chem       Date:  1986-01-25       Impact factor: 5.157

5.  Theoretical model studies of drug absorption and transport in the GI tract. 3.

Authors:  N F Ho; W I Higuchi; J Turi
Journal:  J Pharm Sci       Date:  1972-02       Impact factor: 3.534

6.  Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2.

Authors:  A H Dantzig; L Bergin
Journal:  Biochim Biophys Acta       Date:  1990-09-07

7.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

8.  Evidence for two disulfide bonds important to the functioning of the renal outer cortical brush-border membrane D-glucose transporter.

Authors:  R J Turner; J N George
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

9.  Drug absorption by the rat jejunum perfused in situ. Dissociation from the pH-partition theory and role of microclimate-pH and unstirred layer.

Authors:  M L Högerle; D Winne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

10.  Short-chain fatty acid transport in the intestine of a herbivorous teleost.

Authors:  E Titus; G A Ahearn
Journal:  J Exp Biol       Date:  1988-03       Impact factor: 3.312

View more
  25 in total

1.  Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.

Authors:  E Liang; J Proudfoot; M Yazdanian
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  Pharmacokinetic and pharmacodynamic evaluation for tissue-selective inhibition of cholesterol synthesis by pravastatin.

Authors:  T Hatanaka; S Honda; S Sasaki; K Katayama; T Koizumi
Journal:  J Pharmacokinet Biopharm       Date:  1998-06

3.  Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.

Authors:  Yoko Honda; Fumihiko Ushigome; Noriko Koyabu; Satoshi Morimoto; Yukihiro Shoyama; Takeshi Uchiumi; Michihiko Kuwano; Hisakazu Ohtani; Yasufumi Sawada
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

4.  Intestinal absorption of miltefosine: contribution of passive paracellular transport.

Authors:  Cécile Ménez; Marion Buyse; Christophe Dugave; Robert Farinotti; Gillian Barratt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

5.  Carrier-mediated transport can obey fractal kinetics.

Authors:  P Macheras
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

Review 6.  Carrier-mediated intestinal transport of drugs.

Authors:  A Tsuji; I Tamai
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

7.  Adsorptive-mediated transcytosis of a synthetic basic peptide, 001-C8 in Caco-2 cells.

Authors:  Y Sai; M Kajita; I Tamai; J Wakama; T Wakamiya; A Tsuji
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

8.  Influence of chitosan microspheres on the transport of prednisolone sodium phosphate across HT-29 cell monolayers.

Authors:  F C Mooren; A Berthold; W Domschke; J Kreuter
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

9.  Application of fractal kinetics for carrier-mediated transport of drugs across intestinal epithelial membrane.

Authors:  T Ogihara; I Tamai; A Tsuji
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

10.  Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1.

Authors:  Atsuko Okamura; Akiko Emoto; Noriko Koyabu; Hisakazu Ohtani; Yasufumi Sawada
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.